DSpace Repository

Hemorrhagik Sindrome in Chronik Diffuze Liver Diseases

Show simple item record

dc.contributor.author Kurbonova, Z.Ch.
dc.contributor.author Babadjanova, Sh.A.
dc.contributor.author Filiz, Maraşlıoğlu
dc.contributor.author Sayfutdinova, Z.A.
dc.contributor.author Shodiyeva, G.E.
dc.date.accessioned 2023-04-06T13:53:00Z
dc.date.available 2023-04-06T13:53:00Z
dc.date.issued 2023-03
dc.identifier.issn 2795-7624
dc.identifier.uri http://repository.tma.uz/xmlui/handle/1/6953
dc.description.abstract The main signs of hemorrhagic syndrome in chronic hepatitis and liver cirrhosis with viral etiology were divided into the nosebleeds in 32.76%, gums bleeding in 27.59%, skin petechia in 25.0%, hemorrhoidal bleeding in 19.83%, bleeding from varicose veins of the esophagus in 18.96%, menorrhage in 17.24% and bleeding from the gastrointestinal tract in 16.38% of patients. Hemorrhagic syndrome was expressed in cirrhosis of the liver HBV and HBV + HDV etiology 57.14% and 62.50%, respectively, to a lesser extent with cirrhosis of the liver HCV etiology 34.78%, but in liver cirrhosis of non-viral etiology hemorrhagic syndrome was detected in 25% of cases. In chronic viral hepatitis HBV and HCV etiology hemorrhagic syndrome was 11.76% and 5.26%, respectively, which indicated a lesser violation of the hemostasis system than in liver cirrhosis with viral etiology. As soon as there is a pronounced hemorrhagic syndrome in liver cirrhosis with viral etiology, a detailed study of coagulation and vascular platelet hemostasis is required to prevent and treat bleeding syndrome en_US
dc.language.iso en en_US
dc.publisher Eurasian Medical Research Periodical en_US
dc.relation.ispartofseries 18;
dc.subject hemorrhagic syndrome, liver cirrhosis, chronic hepatitis, hemostasis en_US
dc.title Hemorrhagik Sindrome in Chronik Diffuze Liver Diseases en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account